✦ LIBER ✦

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF

✍ Scribed by Mike G. Martin; Kristan M. Augustin; Geoffrey L. Uy; John S. Welch; Lindsay Hladnik; Sagun Goyal; Divya Tiwari; Ryan S. Monahan; Richard M. Reichley; Amanda F. Cashen; Keith Stockerl-Goldstein; Peter Westervelt; Camille N. Abboud; John F. DiPersio; Ravi Vij

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 140 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21545

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of cytarabine given as a co

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia

✍ Fevzi Ozkaynak, M.; Avramis, Vassilios I.; Carcich, Sherri; Ortega, Jorge A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Background. The outcome of patients with acute myeloid leukemia (AML) who relapse or fail to achieve an initial remission has been dismal. Procedure. Fifteen pediatric patients with AML, 4 relapsed and 11 primary refractory, were reinduced with a loading bolus of 0.5 g/m 2 cytarabine (ara-C) followe